EHA creates clinical practice Guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of the EHA Guidelines Committee and the definition of the EHA Methodology for Guidelines.

Since then, in addition to developing its own Guidelines, EHA Guidelines has established a framework for collaboration with ESMO (European Society for Medical Oncology) to produce Guidelines on hematologic malignancies, as well as on other hematologic diseases with EuNet-INNOCHRON, EuroBloodNet, British Society of Hematology (BSH), International Society of Amyloidosis (ISA), European Association for Haemophilia and Allied Disorders (EAHAD), and the International Society on Thrombosis and Haemostasis (ISTH). EHA further promotes strong collaboration with the EHA-SWGs and other medical societies and associations.

Collaborations with:

Achievements in 2023:

Successful orchestration of five Guidelines Sessions during the EHA2023 Congress.

Active engagement of the Guideline Chairs with National EHA Society Representatives.

Continued publication of key EHA Guideline papers in HemaSphere.

Successful launch of the EHA Guidelines App.